# GOSS (Gossamer Bio, Inc.) - SEC EDGAR Financial Statements

> Gossamer Bio, Inc. reported $78.42M in revenue and a net loss of $125.1M for the trailing twelve months ended September 30, 2026 (up 189.1% year over year), with a -140.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/GOSS
- Markdown: https://convexityos.com/fundamentals/GOSS.md
- SEC CIK: 0001728117
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:51 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001728117&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $78.42M | +189.1% YoY |
| Operating Income | TTM | -$109.8M | -140.0% margin |
| Net Income | TTM | -$125.1M | -159.5% net margin |
| Diluted EPS | TTM | -$19.15 | Split-adjusted |
| Free Cash Flow | TTM | -$156.0M | -199.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $51.19M | Total debt: $3.70M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $48.47M | $114.7M | $0 | $0 | -- | -- | -- | -- | -- |
| Research & Development | $174.1M | $138.5M | $135.3M | $170.9M | $170.3M | $160.9M | $143.4M | $55.28M | $891K |
| Total Operating Expenses | $219.2M | $174.6M | $183.8M | $218.6M | $216.1M | $234.0M | $186.1M | $149.0M | $6.65M |
| **Operating Income** | -$170.7M | -$59.92M | -$183.8M | -$218.6M | -$216.1M | -$234.0M | -$186.1M | -$149.0M | -$6.65M |
| **EBITDA** | -$170.7M | -$59.09M | -$182.2M | -$216.8M | -$214.4M | -$232.6M | -$185.2M | -$148.7M | -$6.65M |
| Interest Income | $1.97M | $1.78M | $2.00M | $1.58M | $761K | $3.44M | $5.56M | $1.72M | -- |
| Interest Expense | $10.99M | $11.52M | $13.51M | $13.88M | $19.44M | $12.67M | $1.94M | $12K | -- |
| Income Before Tax | -$170.5M | -$55.63M | -$179.8M | -$229.4M | -$234.0M | -$243.4M | -$180.3M | -$147.0M | $6.77M |
| Income Tax Expense | -$88K | $893K | $0 | $0 | -- | -- | $0 | $0 | $0 |
| **Net Income** | -$170.4M | -$56.53M | -$179.8M | -$229.4M | -$234.0M | -$243.4M | -$180.3M | -$147.0M | -$6.77M |
| Basic EPS | -$60.00 | -$20.00 | -$94.40 | -$216.80 | -$250.40 | -$284.00 | -$263.20 | -$1,807.20 | -$59.20 |
| **Diluted EPS** | -$60.00 | -$20.00 | -$94.40 | -$216.80 | -$250.40 | -$284.00 | -$263.20 | -$1,807.20 | -$59.20 |
| Basic Shares Outstanding | 2.9M | 2.8M | 1.9M | 1.1M | 935.5K | 856.4K | 684.3K | 81.3K | 114.5K |
| Diluted Shares Outstanding | 2.9M | 2.8M | 1.9M | 1.1M | 935.5K | 856.4K | 684.3K | 81.3K | 114.5K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $38.43M | $9.24M | $16.95M | $13.80M | $13.29M | $11.49M | $9.89M | $9.38M |
| Research & Development | $18.83M | $26.41M | $43.08M | $48.94M | $45.54M | $41.58M | $38.04M | $36.11M |
| Total Operating Expenses | $31.24M | $35.31M | $61.82M | $59.84M | $62.41M | $50.25M | $46.70M | $45.51M |
| **Operating Income** | $7.20M | -$26.07M | -$44.87M | -$46.04M | -$49.11M | -$38.77M | -$36.81M | -$36.13M |
| **EBITDA** | -- | -- | -$44.86M | -$46.03M | -$49.11M | -$38.76M | -$36.80M | -$36.02M |
| Interest Income | $400K | $268K | $354K | $447K | $687K | $542K | $294K | -$744K |
| Interest Expense | $2.46M | $2.71M | $2.75M | $2.75M | $2.75M | $2.74M | $2.75M | $2.74M |
| Income Before Tax | -- | -- | -- | -- | -$48.22M | -$38.27M | -- | -- |
| Income Tax Expense | -- | -- | -- | -- | $0 | $0 | -- | -- |
| **Net Income** | -$48.07M | $16.90M | -$46.66M | -$47.24M | -$48.22M | -$38.27M | -$36.64M | -$33.03M |
| Basic EPS | -$7.36 | $4.00 | -$16.00 | -- | -$16.92 | -$13.60 | -$12.80 | -- |
| **Diluted EPS** | -$7.36 | -$6.40 | -$16.00 | -- | -$16.92 | -$13.60 | -$12.80 | -- |
| Basic Shares Outstanding | 6.5M | 4.0M | 2.9M | -- | 2.8M | 2.8M | 2.8M | -- |
| Diluted Shares Outstanding | 6.5M | 4.1M | 2.9M | -- | 2.8M | 2.8M | 2.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $37.73M | $46.07M | $32.11M | $112.0M | $183.4M | $486.1M | $135.0M | $105.2M |
| Short-Term Investments | $99.20M | $248.4M | $264.3M | $143.7M | $141.8M | $26.57M | $266.7M | $123.4M |
| **Cash & Short-Term Investments** | $136.9M | $294.5M | $296.4M | $255.7M | $325.2M | $512.6M | $401.8M | $228.7M |
| Accounts Receivable, Net | $12.23M | $5.34M | $0 | -- | -- | -- | -- | -- |
| **Total Current Assets** | $167.6M | $309.9M | $306.5M | $261.9M | $331.8M | $522.3M | $409.3M | $232.0M |
| Property, Plant & Equipment, Net | $64K | $10K | $1.65M | $3.98M | $5.32M | $5.53M | $5.42M | $3.19M |
| Long-Term Investments | $0 | -- | -- | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $408K | $283K | $618K | $680K | $1.08M | $1.03M | $1.56M | $4.27M |
| **Total Non-Current Assets** | $4.61M | $5.40M | $5.40M | $10.57M | $11.88M | $17.11M | $17.29M | $7.47M |
| **Total Assets** | $172.2M | $315.3M | $311.9M | $272.4M | $343.7M | $539.4M | $426.6M | $239.4M |
| Accounts Payable | $5.96M | $2.32M | $5.53M | $1.46M | $3.24M | $7.51M | $956K | $2.18M |
| Short-Term Debt | -- | $0 | $11.61M | $11.61M | $0 | -- | -- | -- |
| Deferred Revenue (Current) | $19.99M | $17.05M | $0 | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $63.44M | $45.01M | $51.60M | $49.23M | $39.86M | $38.65M | $36.92M | $20.40M |
| Long-Term Debt | -- | $0 | $814K | $11.99M | $29.08M | $28.74M | $28.46M | -- |
| Deferred Revenue (Non-Current) | $29.61M | $38.87M | $0 | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $231.6M | $240.8M | $197.5M | $211.1M | $182.3M | $180.1M | $37.20M | $718K |
| **Total Liabilities** | $295.0M | $285.8M | $249.1M | $260.4M | $222.2M | $218.7M | $74.12M | $21.12M |
| **Total Debt (incl. Leases)** | $4.40M | $5.36M | $15.87M | $30.03M | $35.20M | $40.09M | $39.55M | -- |
| Common Stock | $0 | $23K | $23K | $10K | $8.0K | $8.0K | $7.0K | $2.0K |
| Retained Earnings | -$1.44B | -$1.27B | -$1.21B | -$1.03B | -$811.5M | -$577.5M | -$334.2M | -$153.9M |
| Accumulated Other Comp. Income | -$5.15M | $1.19M | -$350K | -$574K | $45K | $599K | $258K | -$61K |
| **Total Stockholders' Equity** | -$122.8M | $29.49M | $62.77M | $12.08M | $121.5M | $320.7M | $352.5M | -$120.1M |
| Total Equity | -$122.8M | $29.49M | $62.77M | $12.08M | $121.5M | $320.7M | $352.5M | -$120.1M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $51.19M | $41.15M | $41.03M | $37.73M | $8.93M | $26.31M | $29.02M | $46.07M |
| Short-Term Investments | $0 | $15.88M | $58.19M | $99.20M | $171.3M | $186.6M | $228.9M | $248.4M |
| **Cash & Short-Term Investments** | $51.19M | $57.03M | $99.22M | $136.9M | $180.2M | $212.9M | $257.9M | $294.5M |
| Accounts Receivable, Net | $0 | $6.11M | $9.25M | $12.23M | $9.24M | $7.58M | $6.58M | $5.34M |
| **Total Current Assets** | $60.43M | $72.72M | $124.5M | $167.6M | $204.0M | $235.9M | $275.5M | $309.9M |
| Property, Plant & Equipment, Net | $51K | $55K | $59K | $64K | $70K | $76K | $29K | $10K |
| Long-Term Investments | -- | $0 | $0 | $0 | $0 | $0 | $0 | -- |
| Other Non-Current Assets | $424K | $429K | $398K | $408K | $407K | $383K | $310K | $283K |
| **Total Non-Current Assets** | $3.91M | $4.14M | $4.36M | $4.61M | $4.83M | $5.03M | $5.11M | $5.40M |
| **Total Assets** | $64.34M | $76.87M | $128.9M | $172.2M | $208.8M | $240.9M | $280.6M | $315.3M |
| Accounts Payable | $1.47M | $5.95M | $10.82M | $5.96M | $1.12M | $1.88M | $3.39M | $2.32M |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | $0 |
| Deferred Revenue (Current) | $0 | $7.07M | $8.74M | $19.99M | $23.97M | $23.47M | $17.85M | $17.05M |
| **Total Current Liabilities** | $99.94M | $137.8M | $56.51M | $63.44M | $62.12M | $53.59M | $48.22M | $45.01M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | $0 |
| Deferred Revenue (Non-Current) | $0 | $30.16M | $31.90M | $29.61M | $27.08M | $31.50M | $36.68M | $38.87M |
| **Total Non-Current Liabilities** | $87.19M | $33.11M | $233.9M | $231.6M | $229.0M | $233.4M | $238.6M | $240.8M |
| **Total Liabilities** | $187.1M | $170.9M | $290.4M | $295.0M | $291.2M | $287.0M | $286.8M | $285.8M |
| **Total Debt (incl. Leases)** | $3.70M | $3.92M | $4.17M | $4.40M | $4.62M | $4.82M | $5.02M | $5.36M |
| Common Stock | $1.0K | $50K | $24K | $0 | $24K | $23K | $23K | $23K |
| Retained Earnings | -$1.52B | -$1.47B | -$1.49B | -$1.44B | -$1.39B | -$1.34B | -$1.31B | -$1.27B |
| Accumulated Other Comp. Income | -$3.62M | -$3.73M | -$4.02M | -$5.15M | -$5.11M | -$5.09M | -$824K | $1.19M |
| **Total Stockholders' Equity** | -$122.8M | -$94.03M | -$161.5M | -$122.8M | -$82.33M | -$46.11M | -$6.25M | $29.49M |
| Total Equity | -$122.8M | -$94.03M | -$161.5M | -$122.8M | -$82.33M | -$46.11M | -$6.25M | $29.49M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$170.4M | -$56.53M | -$179.8M | -$229.4M | -$234.0M | -$243.4M | -$180.3M | -$147.0M | -$6.77M |
| Depreciation & Amortization | $24K | $833K | $1.61M | $1.83M | $1.74M | $1.41M | $917K | $297K | $0 |
| Stock-Based Compensation | $10.55M | $20.62M | $28.52M | $42.55M | $32.01M | $38.75M | $20.82M | $30.95M | $32K |
| Change in Receivables | -$6.89M | -$5.34M | $0 | $0 | -- | -- | -- | -- | -- |
| Change in Payables | -$2.75M | -$1.66M | $3.99M | -$1.81M | -$4.43M | $6.98M | -$1.40M | $2.08M | $57K |
| **Operating Cash Flow** | -$171.3M | -$3.47M | -$159.2M | -$187.0M | -$188.9M | -$176.4M | -$144.8M | -$51.04M | -$5.75M |
| Capital Expenditure | -$79K | $0 | $0 | -$410K | -$1.55M | -$1.50M | -$2.97M | -$3.49M | -- |
| **Free Cash Flow** | -$171.3M | -$3.47M | -$159.2M | -$187.4M | -$190.4M | -$177.9M | -$147.8M | -$54.53M | -- |
| Purchases of Investments | -$227.1M | -$494.8M | -$441.7M | -$238.1M | -$152.0M | -$109.0M | -$499.1M | -$123.5M | -- |
| **Investing Cash Flow** | $156.4M | $29.02M | -$111.0M | -$1.03M | -$117.4M | $215.3M | -$147.1M | -$144.7M | -- |
| Common Stock Issued | -- | -- | -- | $0 | $0 | $117.1M | $291.3M | $0 | -- |
| **Financing Cash Flow** | $6.42M | -$11.49M | $190.2M | $117.1M | $3.33M | $312.5M | $321.6M | $300.9M | $6.00M |
| **Net Change in Cash** | -$8.34M | $13.96M | -$79.86M | -$71.49M | -$303.2M | $351.5M | $29.67M | $105.1M | $255K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$48.07M | $16.90M | -$46.66M | -$47.24M | -$48.22M | -$38.27M | -$36.64M | -$33.03M |
| Depreciation & Amortization | -- | -- | $5.0K | $6.0K | $6.0K | $6.0K | $6.0K | $108K |
| Stock-Based Compensation | $3.79M | $2.46M | $6.30M | $2.90M | $2.67M | $2.59M | $2.40M | $4.96M |
| Change in Receivables | $3.66M | $3.15M | $2.98M | -$2.98M | -$1.66M | -$996K | -$1.25M | $1.25M |
| Change in Payables | -$4.70M | -$4.59M | $6.16M | $4.82M | -$795K | -$5.84M | -$937K | $3.08M |
| **Operating Cash Flow** | -$29.58M | -$39.42M | -$38.72M | -$48.31M | -$36.17M | -$47.06M | -$39.72M | -$35.48M |
| Capital Expenditure | $0 | $0 | $0 | $0 | $0 | -$53K | -$26K | $0 |
| **Free Cash Flow** | -$29.58M | -$39.42M | -$38.72M | -$48.31M | -$36.17M | -$47.11M | -$39.75M | -$35.48M |
| Purchases of Investments | $0 | $0 | -$24.99M | -$20.99M | -$29.59M | -$75.52M | -$101.0M | -$83.68M |
| **Investing Cash Flow** | $15.90M | $42.70M | $41.61M | $73.16M | $17.01M | $44.13M | $22.06M | $53.22M |
| **Financing Cash Flow** | $23.72M | -$3.14M | $512K | $3.96M | $1.87M | $94K | $504K | $0 |
| **Net Change in Cash** | $10.04M | $120K | $3.30M | $28.80M | -$17.38M | -$2.71M | -$17.05M | $17.61M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -352.2% | -52.2% | -- | -- | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -351.5% | -49.3% | -- | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -- | -191.7% | -286.5% | -1899.3% | -192.7% | -75.9% | -51.2% | -- | -- |
| Return on Assets (ROA) | -98.9% | -17.9% | -57.6% | -84.2% | -68.1% | -45.1% | -42.3% | -61.4% | -- |
| Current Ratio | 2.64x | 6.88x | 5.94x | 5.32x | 8.32x | 13.51x | 11.09x | 11.37x | -- |
| Quick Ratio | 2.35x | 6.66x | 5.74x | 5.19x | 8.16x | 13.26x | 10.88x | 11.21x | -- |
| Debt to Equity | -- | 0.18x | 0.25x | 2.49x | 0.29x | 0.13x | 0.11x | -- | -- |
| **Revenue Growth (YoY)** | -57.7% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -140.0% | -311.7% | -321.9% | -352.2% | -365.1% | -361.9% | -44.0% | -52.2% |
| **Net Profit Margin** | -159.5% | -235.0% | -324.8% | -351.5% | -354.5% | -344.8% | -41.1% | -49.3% |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -- | -191.7% |
| Return on Assets (ROA) | -194.4% | -162.9% | -140.0% | -98.9% | -74.8% | -57.6% | -18.3% | -17.9% |
| Current Ratio | 0.60x | 0.53x | 2.20x | 2.64x | 3.28x | 4.40x | 5.71x | 6.88x |
| Quick Ratio | 0.51x | 0.46x | 1.92x | 2.35x | 3.05x | 4.11x | 5.49x | 6.66x |
| Debt to Equity | -- | -- | -- | -- | -- | -- | -- | 0.18x |
| **Revenue Growth (YoY)** | +189.1% | -19.6% | +71.5% | +47.1% | +40.2% | -88.0% | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -174.4% | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -177.7% | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -177.3% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -140.4% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -140.5% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
